| Prev Close | 5.63 |
| Open | 5.70 |
| Day Low/High | 5.54 / 5.71 |
| 52 Wk Low/High | 3.09 / 10.25 |
| Volume | 85.28K |
| Avg Volume | 97.90K |
| Exchange | AMEX |
| Shares Outstanding | 37.08M |
| Market Cap | 207.64M |
| EPS | -1.40 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
8 Biotech Stocks Under $10 Making Big Moves Higher
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
RSI Alert: Medgenics (MDGN) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
MDGN: Insiders vs. Shorts
The most recent short interest data was recently released by the NASDAQ for the 12/15/2015 settlement date, and Medgenics Inc is one of the most shorted stocks of the Russell 3000, based on 13.54 "days to cover" versus the median component at 5.46. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
5 Stocks Insiders Love Right Now
Insiders at these companies have been scooping up shares of their own stock lately.
MDGN: Insiders vs. Shorts
The most recent short interest data was recently released by the NASDAQ for the 09/15/2015 settlement date, and Medgenics Inc is one of the most shorted stocks of the Russell 3000, based on 9.38 "days to cover" versus the median component at 6.87. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
The shares of Spark Therapeutics are surging after the company announced that its lead gene therapy product candidate had met its primary endpoint in a Phase 3 trial.
Short Interest Increases 15% For MDGN
The most recent short interest data has been released by the NASDAQ for the 08/14/2015 settlement date, which shows a 270,220 share increase in total short interest for Medgenics Inc , to 2,060,407, an increase of 15.09% since 07/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Short Interest Expands By 61.4% For MDGN
The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 498,506 share increase in total short interest for Medgenics Inc , to 1,309,814, an increase of 61.44% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Medgenics Becomes Oversold (MDGN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
